RPG Life Sciences Submits SEBI Regulation 74(5) Compliance Certificate for Q2 FY26
RPG Life Sciences submitted a certificate from MUFG Intime India Private Limited confirming compliance with SEBI Regulation 74(5) for the quarter ended September 30, 2025, regarding dematerialisation of securities.
This is a standard, mandatory compliance report that all listed companies must file. It does not contain information that would typically move the stock price or have a significant impact on investors.
The announcement is a routine regulatory compliance filing, indicating standard operational adherence without presenting any new positive or negative financial or operational developments.
RPG Life Sciences Limited has submitted a certificate dated October 04, 2025, from MUFG Intime India Private Limited, their Registrar and Transfer Agents. * The certificate confirms compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. * It pertains to the quarter ended September 30, 2025. * The Registrar confirmed that securities received for dematerialisation during the quarter were duly processed (confirmed/rejected) to the depositories. * These securities have been listed on the stock exchanges where earlier issued securities are listed. * Furthermore, security certificates received for dematerialisation were mutilated and cancelled after verification, and the names of the depositories were substituted in the register of members within prescribed timelines.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.